Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

C4 Therapeutics (CCCC) Preferred Dividend Payments (2020)

Historic Preferred Dividend Payments for C4 Therapeutics (CCCC) over the last 1 years, with Q3 2020 value amounting to $5.2 million.

  • C4 Therapeutics' Preferred Dividend Payments changed N/A to $5.2 million in Q3 2020 from the same period last year, while for Sep 2020 it was $13.1 million, marking a year-over-year change of. This contributed to the annual value of $8.5 million for FY2019, which is N/A changed from last year.
  • Per C4 Therapeutics' latest filing, its Preferred Dividend Payments stood at $5.2 million for Q3 2020.
  • Over the past 5 years, C4 Therapeutics' Preferred Dividend Payments peaked at $5.2 million during Q3 2020, and registered a low of $2.1 million during Q1 2020.